182 filings
Page 3 of 10
8-K
lfxyj7vj vn
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
jo7ls9 gm63nftg
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
s64jodyjkd p9cug9
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
pygpsouxxjnwa4uobfo
9 Aug 22
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
7:11am
S-8
4n6ifpolqmnogctl3h
9 Aug 22
Registration of securities for employees
12:00am
8-K
pyttq4hnrnc4w
29 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
mo7vqy huct
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
g5i9ihg8 f5kaf0d3ayp
24 May 22
Regulation FD Disclosure
7:00am
8-K
f2mh1z1jrqj7f74
18 May 22
AVROBIO Announces Preclinical Gene Therapy Data for Pompe Disease at American Society of Gene and Cell Therapy (ASGCT) annual meeting
8:30am
8-K
uxusr l6ew6k
17 May 22
AVROBIO Reports Positive Data from Phase 1/2 Clinical Trial of Investigational
7:12am
8-K
b8r9m88ql1tjovu mto
10 May 22
AVROBIO Reports First Quarter 2022 Financial Results and Provides Business Update
7:05am
DEFA14A
mhq2jb9 jfc1o
27 Apr 22
Additional proxy soliciting materials
5:03pm
S-8
lm0my6tm1evv7 qa0
17 Mar 22
Registration of securities for employees
4:56pm
8-K
imvexlvvqp4 me50zuz0
17 Mar 22
AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
7:54am